Silent myocardial ischemia. II. Pathophysiology, relation to risk factors, treatment

C Velican1, D Sipciu

  • 1N. Gh. Lupu Institute of Internal Medicine, Bucharest, Romania.

Medecine Interne
|July 1, 1989
PubMed

Insights

This review covers silent myocardial ischemia, exploring its causes, risk factors like smoking and stress, and effective medical treatments. Treatment can improve outcomes for coronary heart disease patients.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Silent myocardial ischemia (SMI) is a critical condition often preceding overt coronary heart disease.
  • Understanding SMI pathophysiology and risk factors is vital for early detection and intervention.

Purpose of the Study:

  • To review current hypotheses and findings on SMI.
  • To examine the role of risk factors (smoking, psychosocial stress) in SMI.
  • To summarize the impact of medical treatment on SMI outcomes.

Main Methods:

  • Selective review of existing literature on silent myocardial ischemia.
  • Analysis of major hypotheses, viewpoints, and findings.
  • Evaluation of treatment effects in monitored settings.

Main Results:

  • Pathophysiology of SMI discussed.
  • Influence of smoking and psychosocial stress on SMI precipitation highlighted.
  • Medical treatment demonstrates improvements in laboratory tests, disease progression, and survival rates.

Conclusions:

  • Medical interventions can significantly improve outcomes for patients with silent myocardial ischemia.
  • Risk factor modification, including smoking cessation and stress management, is crucial.
  • Further research into SMI management is warranted.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...